scispace - formally typeset
C

Carola Severi

Researcher at Sapienza University of Rome

Publications -  108
Citations -  3684

Carola Severi is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Internal medicine & Helicobacter pylori. The author has an hindex of 25, co-authored 96 publications receiving 2775 citations. Previous affiliations of Carola Severi include VCU Medical Center & Boston University.

Papers
More filters
Journal Article

The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems

TL;DR: This review summarizes the available evidence supporting the existence of microbiota-GBA interactions, as well as the possible pathophysiological mechanisms involved, and describes the importance of gut microbiota in influencing these interactions.
Journal ArticleDOI

Efficacy of gluten-free diet alone on recovery from iron deficiency anemia in adult celiac patients.

TL;DR: A screening for celiac disease should be carried out in adult patients with iron deficiency anemia and recovery from anemia occurs between 6 and 12 months on a gluten-free diet alone as a consequence of normalization of histological alterations of the intestinal mucosa.
Journal ArticleDOI

Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency.

TL;DR: The non-invasive combined PCA and IFA assessment may be useful in selecting patients at risk for autoimmune gastritis to be confi rmed by gastroscopic–histologic examination.
Journal ArticleDOI

Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified.

TL;DR: The aim of this review is to summarize the recently available data on PPI-related microbiota alterations in each segment of the GI tract and to analyze the possible involvement of PPIs in the pathogenesis of several specific GI diseases.
Journal ArticleDOI

Postbiotic activities of lactobacilli-derived factors.

TL;DR: The identification of soluble factors mediating the beneficial effects of probiotics may present an opportunity not only to understand their fine mechanisms of action, but also to develop effective pharmacological strategies that could integrate the action of treatments with live bacteria.